Product References
ITGBL1 promotes EMT, invasion and migration by activating NF-κB signaling pathway in prostate cancer.
OncoTargets and therapy
Li W,Li S,Yang J,Cui C,Yu M,Zhang Y
PA5-27816 was used in Western Blotting to study the role of ITGBL1 in prostate cancer.
Thu Oct 01 00:00:00 EDT 2020
Downregulation of miR‑505‑3p predicts poor bone metastasis‑free survival in prostate cancer.
Oncology reports
Tang Y,Wu B,Huang S,Peng X,Li X,Huang X,Zhou W,Xie P,He P
PA5-27816 was used in Western Blotting to that miR-505-3p may serve as a predictive marker for bone metastasis of prostate cancer.
Tue Jan 01 00:00:00 EST 2019
N-Myc promotes therapeutic resistance development of neuroendocrine prostate cancer by differentially regulating miR-421/ATM pathway.
Molecular cancer
Yin Y,Xu L,Chang Y,Zeng T,Chen X,Wang A,Groth J,Foo WC,Liang C,Hu H,Huang J
PA5-27816 was used in Western Blotting to determine the molecular mechanisms underlying the N-Myc- driven therapeutic resistance.
Fri Jan 18 00:00:00 EST 2019
Downregulation of miR‑19a‑3p promotes invasion, migration and bone metastasis via activating TGF‑β signaling in prostate cancer.
Oncology reports
Wa Q,Li L,Lin H,Peng X,Ren D,Huang Y,He P,Huang S
Published figure using Nuclear Matrix Protein p84 polyclonal antibody (Product # PA5-27816) in Western Blot
Mon Jan 01 00:00:00 EST 2018
Downregulation of miR-141-3p promotes bone metastasis via activating NF-κB signaling in prostate cancer.
Journal of experimental & clinical cancer research : CR
Huang S,Wa Q,Pan J,Peng X,Ren D,Huang Y,Chen X,Tang Y
PA5-27816 was used in Western Blotting to unravel a novel mechanism underlying the bone metastasis of PCa, suggesting that miR-141-3p mimics might represent a potential therapeutic avenue for the treatment of PCa bone metastasis.
Mon Dec 04 00:00:00 EST 2017
Oncogenic miR-210-3p promotes prostate cancer cell EMT and bone metastasis via NF-κB signaling pathway.
Molecular cancer
Ren D,Yang Q,Dai Y,Guo W,Du H,Song L,Peng X
PA5-27816 was used in Western Blotting to demonstrate that miR-210-3p maintains the sustained activation of NF-κB signaling via targeting negative regulators of NF-κB signaling (TNF-α Induced Protein 3 Interacting Protein 1) TNIP1 and (Suppressor Of Cytokine Signaling 1) SOCS1, resulting in EMT, invasion, migration and bone metastasis of PCa cells.
Mon Jul 10 00:00:00 EDT 2017